T lymphocytes are exquisitely sensitive to the antiproliferative effects of
nitric oxide. We examined the effects of
oral administration of two
nitric oxide synthase inhibitors, Nw-nitro-
L-arginine methyl ester (
L-NAME) and
L-N6-(1-iminoethyl)lysine (L-NIL), on the course of T cell-dependent autoimmune
interstitial nephritis in Brown Norway rats. Kidneys from rats immunized to produce
interstitial nephritis display a net generation of
nitric oxide end products. By immunohistochemical staining, the
cytokine-
inducible nitric oxide synthase (iNOS) is expressed in cortical tubular epithelial cells. Treatment with either inhibitor results in markedly more severe disease following immunization. Animals receiving
L-NAME were hypertensive, while those treated with L-NIL, a highly selective inhibitor of iNOS, were not. Evaluation of the expression of IFN-gamma,
IL-2, and
IL-4 in diseased kidneys by quantitative
reverse transcriptase-PCR demonstrated that
L-NAME-treated animals displayed significantly augmented levels of IFN-gamma and
IL-2 with preserved ratios of IFN-gamma/IL-4 and IL-2/IL-4, while L-NIL-treated animals had augmented levels of
IL-2 and IFN-gamma with augmented IFN-gamma/IL-4 and IL-2/IL-4 ratios. Animals treated with
L-NAME or L-NIL both had augmented Ag-specific
IgG responses. The
L-NAME group demonstrated increases in both the
IgG2a and
IgG1 subtypes, with a constant
IgG2a/
IgG1 ratio, while the L-NIL group demonstrated an increase in the ratio of the
IgG2a/
IgG1 response. These Ab and
cytokine data suggest that the L-NIL-treated animals had a skewing of their immune response toward a Th1-like response. We conclude that in autoimmune
interstitial nephritis, generation of
nitric oxide through the iNOS pathway has host-protective effects, and suggest that this may be broadly applicable to T cell-mediated pathologies.